Anisimová E, Barták P, Vlcek D, Hirsch I, Brichácek B, Vonka V
Department of Experimental Virology, Institute of Sera and Vaccines, Praha, Czechoslovakia.
J Gen Virol. 1990 Feb;71 ( Pt 2):419-22. doi: 10.1099/0022-1317-71-2-419.
Sera from 75 patients with warts were tested for antibodies against human papillomaviruses (HPVs) in an immunoelectron microscopy test. A group of 40 patients' sera were tested against a pooled suspension of the HPVs extracted from their warts and 90% of the sera were found to be antibody-positive. Prior to serological investigation viruses from a second group of 35 patients were typed by dot blot hybridization with HPV-1 and HPV-2 DNA. According to these results the patients were divided into type 1, type 2 and non-1, non-2 virus carriers. Sera of these patients were first tested for antibodies reactive with their homologous viruses and then for antibodies against type 1 virus. More than 80% of the patients possessed antibodies against their homologous viruses, but only a small minority of sera from type 2 and non-1, non-2 virus carriers were reactive with type 1 viruses. These results suggest that the antibody reactive in the immunoaggregation test is type-specific.
采用免疫电子显微镜试验检测了75例疣患者血清中的人乳头瘤病毒(HPV)抗体。从40例患者的疣中提取HPV,制备混合悬液,用该悬液检测这40例患者的血清,发现90%的血清抗体呈阳性。在进行血清学研究之前,采用HPV-1和HPV-2 DNA斑点杂交法对另外35例患者的病毒进行分型。根据这些结果,将患者分为1型、2型和非1、非2型病毒携带者。首先检测这些患者血清中与同源病毒反应的抗体,然后检测抗1型病毒的抗体。超过80%的患者拥有针对其同源病毒的抗体,但2型和非1、非2型病毒携带者的血清中只有一小部分与1型病毒发生反应。这些结果表明,免疫凝集试验中反应的抗体具有型特异性。